Phentermine and Jakafi drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Phentermine (phentermine hydrochloride) and Jakafi (ruxolitinib phosphate). Common drug interactions include blood iron decreased among females.
The phase IV clinical study analyzes what interactions people have when they take Phentermine and Jakafi. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.
What is Phentermine?
Phentermine has active ingredients of phentermine hydrochloride. It is often used in weight loss. eHealthMe is studying from 19,870 Phentermine users. Check the latest studies of Phentermine.
What is Jakafi?
Jakafi has active ingredients of ruxolitinib phosphate. It is often used in primary myelofibrosis. eHealthMe is studying from 56,530 Jakafi users. Check the latest studies of Jakafi.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
21 people who take Phentermine and Jakafi together, and have interactions are studied.
What are the common drug interactions of Phentermine and Jakafi, by gender? *:
female:
- Blood iron decreased
- Blood pressure increased
- Weight increased
- Lacrimation increased
- Cardiac flutter (abnormal heart rhythm)
- Hot flush (sudden feelings of heat)
- Hypersensitivity
- Memory impairment
- Nausea (feeling of having an urge to vomit)
- Palpitations (feelings or sensations that your heart is pounding or racing)
male:
n/a
What are the existing conditions these people have? *
- Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 19 people, 90.48%
- Weight Loss: 17 people, 80.95%
- Essential Thrombocythaemia (chronic blood cancer): 2 people, 9.52%
* Approximation only. Some reports may have incomplete information.
Do you take Phentermine and Jakafi?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Phentermine (19,870 reports)
- Jakafi (56,530 reports)
Browse all drug interactions of Phentermine and Jakafi:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Phentermine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Jakafi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Phentermine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Jakafi and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on phentermine hydrochloride and ruxolitinib phosphate (the active ingredients of Phentermine and Jakafi, respectively), and Phentermine and Jakafi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Uterine Haemorrhage and drugs of ingredients of anastrozole - now
- Abdominal Pain in Prilosec, how severe and when it was recovered? - a second ago
- Could Methotrexate cause Acne? - a second ago
- Could Emtriva cause Kidney Stones? - a second ago
- Lipodystrophy Acquired and drugs of ingredients of sulfamethoxazole; trimethoprim - a second ago
- Minirin vs. Novolog, side effect and effectiveness comparison - 2 seconds ago
- Drug interactions of Biotin and Acyclovir - 3 seconds ago
- Could Jardiance cause Eating Disorder? - 3 seconds ago
- Oropharyngeal Discomfort and drugs of ingredients of indomethacin - 4 seconds ago
- Drowsiness and drugs of ingredients of methylprednisolone - 5 seconds ago